Skip to main content
Log in

Vitamin D levels and comorbidities in ambulatory and hospitalized patients in Austria

  • original article
  • Published:
Wiener klinische Wochenschrift Aims and scope Submit manuscript

Summary

Vitamin D in its hormonal active form, 1,25-dihydroxyvitamin D (calcitriol), has a major impact on bone turnover by regulating calcium and phosphate homoeostasis. By binding the active vitamin D hormone to the vitamin D receptor (VDR), it acts as a nuclear transcription factor (Bouillon et al., Endocr Rev 29(6):726–776, 2008). The discovery that almost all tissues and cells in the body express the VDR and that several tissues possess the enzymatic capability to convert 25-hydroxyvitamin D (25(OH)-D3; cholecalciferol) to the active form, suggests that vitamin D fulfills various extra-osseous functions (Bouillon et al., Endocr Rev 29(6):726–776, 2008; Holick, N Engl J Med 357(3):266–281, 2007). For example, VDR ensures adequate intestinal calcium absorption by regulating the synthesis of several calcium transport proteins in the duodenum (Bouillon et al., Endocr Rev 29(6):726–776, 2008). Additionally, vitamin D is important for proper muscle function, and some studies suggest it may contribute to prevent type 1 diabetes mellitus, certain autoimmune diseases, hypertension, and several types of cancer (Holick, N Engl J Med 357(3):266–281, 2007).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Bouillon R, Carmeliet G, Verlinden L, et al. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev. 2008;29(6):726–76.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  2. Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357(3):266–81.

    Article  CAS  PubMed  Google Scholar 

  3. Alshahrani F, Aljohani N. Vitamin D: deficiency, sufficiency and toxicity. Nutrients. 2013;5(9):3605–16.

    Article  PubMed Central  PubMed  Google Scholar 

  4. Dawson-Hughes B, Mithal A, Bonjour JP, et al. IOF position statement: vitamin D recommendations for older adults. Osteoporos Int. 2010;21:1151–4.

    Article  CAS  PubMed  Google Scholar 

  5. Dawson-Hughes B, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R. Estimates of optimal vitamin D status. Osteoporos Int. 2005;16(7):713–6.

    Article  CAS  PubMed  Google Scholar 

  6. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr. 2006;84(1):18–28.

    CAS  PubMed  Google Scholar 

  7. Mail LO. 2010. Arznei & Vernunft. (German) http://www.pharmig.at/uploads/AuV_Osteoporose_LL_5811_DE.pdf.

  8. Dachverband Osteologie (DVO) Leitlinie 2014 (German). http://www.dvosteologie.org/uploads/Leitlinie%202014/DVOLeitlinie%20Osteoporose%202014%20Kurzfassung%20und%20Langfassung%2018.%2009.%202014.pdf.

  9. The American Society for Bone and Mineral Research (ASBMR) - current recommendations on vitamin D. http://www.asbmr.org/education-detail?cid=630b3844-37ae-4856-83e0-70a2572eec15#.VXEyeJNcqd4.

  10. van Groningen L, Opdenoordt S, van Sorge A, Telting D, Giesen A, de Boer H. Cholecalciferol loading dose guideline for vitamin D-deficient adults. Eur J Endocrinol. 2010;162(4):805–11.

    Article  PubMed  Google Scholar 

  11. Chapuy MC, Preziosi P, Maamer M, et al. Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int. 1997;7(5):439–43.

    Article  CAS  PubMed  Google Scholar 

  12. Holick MF. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc. 2006;81(3):353–73.

    Article  CAS  PubMed  Google Scholar 

  13. Lips P, Hosking D, Lippuner K, et al. The prevalence of vitamin D inadequacy amongst women with osteoporosis: an international epidemiological investigation. J Intern Med. 2006;260(3):245–54.

    Article  CAS  PubMed  Google Scholar 

  14. Mithal A, Wahl DA, Bonjour J-P, et al., the IOF Committee of Scientific Advisors (CSA) Nutrition Working Group. Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int. 2009;20(11):1807–20.

  15. Christodoulou S, Goula T, Ververidis A, Drosos G. Vitamin D and bone disease. BioMed Res Int. 2013;2013:396541.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  16. Bischoff-Ferrari HA, Dietrich T, Orav EJ, Dawson-Hughes E. Positive association between 25-hydroxy vitamin D levels and bone mineral density: a population-based study of younger and older adults. Am J Med. 2004;116(9):634–9.

    Article  CAS  PubMed  Google Scholar 

  17. Adami S, Bertoldo F, Braga V, et al. 25-hydroxy vitamin D levels in healthy premenopausal women: association with bone turnover markers and bone mineral density. Bone. 2009;45(3):423–6.

    Article  CAS  PubMed  Google Scholar 

  18. Hosseinpanah F, Rambod M, Hossein-Nejad A, Larijani B, Azizi F. Association between vitamin D and bone mineral density in Iranian postmenopausal women. J Bone Miner Metab. 2008;26(1):86–92.

    Article  CAS  PubMed  Google Scholar 

  19. Sigurdsson G, Franzson L, Steingrimsdottir L, Sigvaldason H. The association between parathyroid hormone, vitamin D and bone mineral density in 70-year-old icelandic women. Osteoporos Int. 2000;11(12):1031–5.

    Article  CAS  PubMed  Google Scholar 

  20. Reid IR, Bolland MJ, Grey A. Effects of vitamin D supplements on bone mineral density: a systematic review and meta-analysis. Lancet. 2014;383(9912):146–55.

    Article  CAS  PubMed  Google Scholar 

  21. Bischoff-Ferrari HA, Willett WC, Wong JB, et al. Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. Arch Intern Med. 2009;169(6):551–61.

    Article  CAS  PubMed  Google Scholar 

  22. Bischoff-Ferrari HA, Willett WC, Orav EJ, et al. A pooled analysis of vitamin D dose requirements for fracture prevention. N Engl J Med. 2012;367(1):40–9.

    Article  CAS  PubMed  Google Scholar 

  23. Cranney A, Horsley T, O'Donnell S, et al. Effectiveness and safety of vitamin D in relation to bone health. Evid Rep Technol Assess (Full Rep). 2007 Aug;(158):1–235.

  24. Boonen S, Lips P, Bouillon R, Bischoff-Ferrari HA, Vanderschueren D, Haentjens P. Need for additional calcium to reduce the risk of hip fracture with vitamin D supplementation: evidence from a comparative metaanalysis of randomized controlled trials. J Clin Endocrinol Metab. 2007;92(4):1415–23.

    Article  CAS  PubMed  Google Scholar 

  25. Avenell A, Gillespie WJ, Gillespie LD, O’Connell D. Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis. Cochrane Database Syst Rev. 2009;2:CD000227.

    PubMed  Google Scholar 

  26. Bischoff HA, Stahelin HB, Dick W, et al. Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial. J Bone Miner Res. 2003;18(2):343–51.

    Article  CAS  PubMed  Google Scholar 

  27. Bischoff-Ferrari HA, Dietrich T, Orav EJ, et al. Higher 25-hydoxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged ≥ 60 y. Am J Clin Nutr. 2004;80(3):752–8.

    CAS  PubMed  Google Scholar 

  28. Dukas L, Bischoff HA, Lindpaintner LS, et al. Alfacalcidol reduces the number of fallers in a community-dwelling elderly population with a minimum calcium intake of more than 500 mg daily. J Am Geriatr Soc. 2004;52(2):230–6.

    Article  PubMed  Google Scholar 

  29. Kudlacek S, Schneider B, Peterlik M, et al. Assessment of vitamin D and calcium status in healthy adult Austrians. Eur J Clin Invest. 2003;33(4):323–31.

    Article  CAS  PubMed  Google Scholar 

  30. Prentice A. Vitamin D deficiency: a global perspective. Nutr Rev. 2008;66(10 Suppl. 2):S153–64.

    Article  PubMed  Google Scholar 

  31. Gonzalez-Gross M, Valtuena J, Breidenassel C, et al., the HELENA Study Group. Vitamin D status among adolescents in Europe: the Healthy Lifestyle in Europe by Nutrition in Adolescence study. Br J Nutr. 2012;107(5):755–64.

  32. Snijder MB, van Dam RM, Visser M, et al. Adiposity in relation to vitamin D status and parathyroid hormone levels: a population-based study in older men and women. J Clin Endocrinol Metab. 2005;90(7):4119–23.

    Article  CAS  PubMed  Google Scholar 

  33. Lips P. Vitamin D status and nutrition in Europe and Asia. J Steroid Biochem Mol Biol. 2007;103(3–5):620–5.

    Article  CAS  PubMed  Google Scholar 

  34. Bischoff-Ferrari HA, Willett WC, Wong JB, Giovannucci E, Dietrich T, Dawson-Hughes B. Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA. 2005;293(18):2257–64.

    Article  CAS  PubMed  Google Scholar 

  35. Ruohola JP, Laaksi I, Ylikomi T, et al. Association between serum 25(OH)D concentrations and bone stress fractures in Finnish young men. J Bone Miner Res. 2006;21(9):1483–8.

    Article  CAS  PubMed  Google Scholar 

  36. Lappe J, Cullen D, Haynatzki G, Recker R, Ahlf R, Thompson K. Calcium and vitamin D supplementation decreases incidence of stress fractures in female navy recruits. J Bone Miner Res. 2008;23(5):741–9.

    Article  CAS  PubMed  Google Scholar 

  37. Burgi AA, Gorham ED, Garland CF, et al. High serum 25-hydroxyvitamin D is associated with a low incidence of stress fractures. J Bone Miner Res. 2011;26(10):2371–7.

    Article  CAS  PubMed  Google Scholar 

  38. Cauley JA, Danielson ME, Boudreau R, et al. Serum 25-hydroxyvitamin D and clinical fracture risk in a multiethnic cohort of women: the Women’s Health Initiative (WHI). J Bone Miner Res. 2011;26(10):2378–88.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  39. Gröber U, Spitz J, Reichrath J, Kisters K, Holick MF. Vitamin D: update 2013. From rickets prophylaxis to general preventive healthcare. Dermatoendocrinol. 2013;5(3):e2-331–47.

    Article  Google Scholar 

  40. Nagpal S, Na S, Rathnachalam R. Noncalcemic actions of vitamin D receptor ligands. Endocr Rev. 2005;26(5):662–87.

    Article  CAS  PubMed  Google Scholar 

  41. Dusso AS, Brown AJ, Slatopolsky E. Vitamin D. Am J Physiol Renal Physiol. 2005;289(1):F8–28.

    Article  CAS  PubMed  Google Scholar 

  42. Burghardt AJ, Issever AS, Schwartz AV, et al. High-resolution peripheral quantitative computed tomographic imaging of cortical and trabecular bone microarchitecture in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab. 2010;95(11):5045–55.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  43. Patsch JM, Burghardt AJ, Yap SP, et al. Increased cortical porosity in type 2 diabetic postmenopausal women with fragility fractures. J Bone Miner Res. 2013;28(2):313–24.

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Acknowledgments

The authors cordially thank Mr. Wolfgang Sischka for the electronic extraction of all laboratory data.

Conflict of interest

This investigator initiated study was supported by an independent research grant from Kwizda Pharma Austria. Kwizda Pharma was not involved in the study design or had any admission to patient-related data and findings.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Christian Muschitz MD.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Muschitz, C., Kocijan, R., Stütz, V. et al. Vitamin D levels and comorbidities in ambulatory and hospitalized patients in Austria. Wien Klin Wochenschr 127, 675–684 (2015). https://doi.org/10.1007/s00508-015-0824-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00508-015-0824-5

Keywords

Navigation